Skip to main content
logo
Caris Life Sciences logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
29.69
-0.01 (-0.03%)
Oct 12, 2026, 4:00 PM EDT - Market closed

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
8,3907,612---
Market Cap Growth
-9.45%----
Enterprise Value
8,0507,284---
Last Close Price
29.6926.98---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
110.58294.73---
PS Ratio
8.489.37---
PB Ratio
14.1813.19---
P/TBV Ratio
14.6613.64---
P/FCF Ratio
67.69113.80---
P/OCF Ratio
49.7891.54---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
8.138.97---
EV/EBITDA Ratio
46.26107.54---
EV/EBIT Ratio
52.52161.45---
EV/FCF Ratio
64.94108.88---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.770.74-1.53-11.041.08
Debt / EBITDA Ratio
2.455.45---
Debt / FCF Ratio
3.656.39---
Net Debt / Equity Ratio
-0.58-0.64-1.29-4.86-0.55
Net Debt / EBITDA Ratio
-1.96-5.48-1.72-0.350.52
Net Debt / FCF Ratio
-2.75-5.54-1.41-0.320.42
Asset Turnover
0.911.111.090.54-
Inventory Turnover
3.635.255.244.48-
Quick Ratio
4.757.160.931.863.29
Current Ratio
5.537.851.302.553.77
Return on Equity (ROE)
20.13%-45.37%--293.82%-
Return on Assets (ROA)
8.77%3.84%-42.48%-35.34%-
Return on Capital Employed (ROCE)
14.80%4.50%-144.20%-100.60%-54.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
1.25%-0.89%---
FCF Yield
1.48%0.88%---
Buyback Yield / Dilution
-559.05%-371.04%-1.59%-4.73%-
SEC Filings: 10-K · 10-Q